Recruited 6 months ago to lead the US vaccine strategy, Belgian-Moroccan Moncef Slaoui resigned Tuesday January 12 at the request of the Biden team. Dr Slaoui will step down in a month, after leading the unprecedented effort of the US government to develop a safe and effective vaccine against Covid-19 before the end of 2020. The Moroccan-American immunologist had previously announced his intention to resign a once two vaccines and two therapies for Covid-19 were on the market, a goal that was achieved last month with the approval by U.S. health officials of Moderna and Pfizer’s vaccines. Although the vaccination campaign has not been as rapid as expected in the United States, the speed of vaccine development, overseen by Dr Slaoui, has exceeded expectations. Two vaccines have been authorized in the United States with 95% effectiveness against the virus in less than a year.
Trending
- The withdrawal of French banks from Africa: a symptom of a multipolar world in recomposition
- Water: 8% increase in SODECI’s turnover in the first quarter of 2025
- Beyond recovery: building a sovereign and transformative State
- Africa Global Logistics Congo successfully transports and loads a Rig Floor
- The ECOWAS ECO to be launched as early as 2027: the Ouattara option chosen?
- ECOWAS’s ECO to be launched as early as 2027: Is the Ouattara option chosen?
- Cross-border payments new international distinction for CIB Offshore
- Mali strengthens its budget by 21.720 billion CFA francs